Aqr Capital Management LLC Bio Xcel Therapeutics, Inc. Transaction History

Aqr Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.14 - $2.97 $16,370 - $42,649	14,360 New	14,360 $18,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $252,880 - $337,898	-8,702 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$37.44 - $64.63 $29,877 - $51,574	-798 Reduced 8.4%	8,702 $377,000
Q2 2020 Aug 17, 2020	SELL	$17.62 - $58.71 $100,909 - $336,232	-5,727 Reduced 37.61%	9,500 $504,000
Q1 2020 May 15, 2020	BUY	$12.26 - $41.14 $186,683 - $626,438	15,227 New	15,227 $340,000

3.14M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $14.3M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.